Flux through pyruvate dehydrogenase (PDH) in the heart may be reduced by various forms of injury to the myocardium, or by oxidation of alternative substrates in normal heart tissue. It is important to distinguish these two mechanisms because imaging of flux through PDH based on the appearance of hyperpolarized (HP) [
products, and further regulated by phosphorylation-dephosphorylation of the PDH complex. Because metabolism of fatty acids generates high concentrations of acetyl-CoA, the appearance of HP 13 CO 2 and HP [ 13 C]bicarbonate is markedly inhibited by fats even in normal hearts (25, 27) . Consequently, in addition to disease processes, physiological fluctuations in the concentrations of fatty acids also influence the appearance of HP [ 13 C]bicarbonate. An intervention that stimulates flux through PDH in the presence of fatty acids could remove the effects of substrate competition in detecting oxidation of HP [1- 13 C]pyruvate. One such approach is co-administration of glucose, insulin, and potassium (16) . This mixture has multiple effects on plasma glucose, plasma free fatty acids, and myocardial membrane potential, so any effects on bicarbonate appearance probably reflect a complex interaction between substrate concentrations and direct effects on PDH (4) .
Propionate, a physiological short chain fatty acid, also influences PDH flux. The interaction of propionate with pyruvate metabolism in the heart has been extensively studied using 14 C tracers. Fatty acids of even carbon chain length markedly inhibit appearance of 14 CO 2 from [1-14 C]pyruvate (14, 32) . When compared with acetate, propionate increased the rate of 14 CO 2 production from [1- 14 C]pyruvate under steady state conditions (14) , suggesting that propionate may be an alternative to glucose, insulin, and potassium for stimulating PDH flux. However, the relevance of these studies for HP 13 C NMR observations is unclear, for two reasons. First, the radiotracer studies examined the influence of individual fatty acids such as acetate or propionate on pyruvate metabolism. The effect of propionate on pyruvate metabolism in the presence of even chain fatty acids has not been studied extensively, and it is not known whether the stimulatory effects of propionate on PDH flux overcome the inhibitory effects of fatty acids. Second, the magnitude of the increase in 14 CO 2 appearance from [1-14 C]pyruvate induced by propionate was only about threefold compared with acetate (14) . Because these data were acquired under steady state conditions, it is not clear if HP pyruvate would detect similar effects, since the window for observing the HP species is ϳ2 min.
The purpose of this study was to determine whether the reduced appearance of HP [ 13 C]bicarbonate from HP [1-13 C]pyruvate caused by acetate can be overcome by propionate-induced stimulation of PDH flux. Hearts from C57/bl6 mice were perfused to steady state in the presence of glucose and saturating concentrations of acetate. Acetate is the most avidly metabolized fatty acid, since it freely diffuses into the mitochondria, bypassing carnitine palmitoyl transferase-I. In addition, it is not ␤-oxidized, but can immediately be used to synthesize acetyl-CoA. As such, the acetate perfused heart represents a model where flux through PDH is expected to be maximally inhibited. In addition, to our knowledge, this is the first application of a combination of hyperpolarization and cryoprobe technology to study the perfused mouse heart.
MATERIALS AND METHODS
Materials. [1- 13 C]pyruvic acid and [2-13 C]pyruvic acid were purchased from Sigma-Aldrich Isotec (Miamisburg, OH) or Cambridge Isotope Laboratories (Tewksbury, MA) and used without further purification. The various 13 C isotopomers of sodium acetate, glucose, and propionate were purchased and used as supplied from Cambridge Isotopes (Andover, MA). Trityl-OXO63 free radical was purchased from Oxford Instruments Molecular Biotools (Oxford, UK).
Protocol. The protocol was approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center. Female mice, 14 -16 wk in age, were purchased from Charles River and housed four to a cage. All animals were fed ad libitum. A single ketamine (43 mg/kg) and xylazine (8.7 mg/kg) intraperitoneal injection was used for general anesthesia. Depth of anesthesia was assessed by observation of the respiratory rate, paw pinch reflex, and palpebral reflex of the animal. Under general anesthesia, the hearts were rapidly excised and arrested in ice-cold perfusion medium. Langendorff perfusions were performed according to Stowe et al. (39) including measurements of developed pressure, coronary flow, heart rate, and O 2 consumption. Briefly, the aorta of the excised heart was cannulated and perfused in nonrecirculating mode at a constant perfusion pressure of 80 cm H2O. A KrebsHenseleit buffered medium containing 25 mM NaHCO3, 118 mM NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 1.2 mM KH2PO4, and 0.5 mM ethylene diamine tetraacetic acid was bubbled continuously with a 95/5 mixture of O2/CO2 gas to maintain a pH of 7.4. The perfusing medium was maintained at 37°C using a water bath.
Two sets of perfusion conditions were used in the studies of HP [1- 13 C]pyruvate. Hearts in group 1 were supplied with 8.25 mM glucose and 2 mM [U- 13 C]acetate with subsequent addition of HP pyruvate (n ϭ 5). Hearts in group 2 were perfused with identical concentrations of glucose and acetate plus 2 mM propionate (n ϭ 5). Additional experiments were performed with unlabeled acetate, [2-13 C]pyruvate, [U- 13 C]glucose, or [U- 13 C]propionate, depending on the experiment. Hearts were freeze-clamped and extracted for 1 H and 13 C NMR spectroscopy.
Dynamic nuclear polarization. All NMR experiments were carried out at 14.1 T using a Bruker Avance 3 HD console (Bruker BioSpin, Billerica, MA) equipped with a 10 mm 13 C cryoprobe operating at a temperature of 15°K. The temperature of the sample was held at 37°C throughout the experiment. Samples of pyruvic acid (5 l) were polarized essentially as described previously (1) . The samples were dissolved and injected by catheter immediately above the heart (25). 13 C NMR spectra were acquired using 15°excitation pulses with a 2-s repetition time. Acquisition was terminated upon completion of 96 single-pulse acquisitions, the perfusion rig was removed from the magnet, and the heart was immediately freeze-clamped for tissue extraction. The time delay between initial injection of pyruvate to freeze-clamping, including all NMR data acquisition from the perfused heart, was ϳ200 s. Peak areas from the DNP experiments were measured by integration.
NMR and isotopomer analysis of tissue extracts. Freeze-clamped hearts were extracted using perchloric acid (27) . 13 C NMR of the extracts was acquired as previously (24) . The resulting multiplets derived from the utilization of the isotopically labeled substrates were fit using a mixed Gaussian/Lorentzian lineshape in the ACD NMR Processor Software (Advanced Chemistry Development, Toronto, Canada). Proton spectra were fitted with the Chenomx software package to obtain lactate and alanine concentrations (Chenomx, Alberta, Canada). Relative peak areas of the resonances adjacent to 12 C versus the 13 C satellites were measured in the 1 H NMR spectrum to obtain a final concentration of the metabolites as well as the 13 Statistical analysis. Significant differences were evaluated using GraphPad Prism (La Jolla, CA) using multiple t-tests with a significance level of P Ͻ 0.05. For the HP data, each resonance was analyzed individually without the assumption of a consistent standard deviation. The False Discovery Rate approach with a rate of 5% was used to suppress random correlations between variables. For comparisons of concentrations and fractional enrichments, simple t-tests were used without further correction. For all graphs, error bars reflect the standard deviation of the data.
RESULTS

Effects of propionate on oxidation of acetate and glucose.
The presence of propionate in the perfusion medium did not alter O 2 consumption (44
. Flux through citrate synthase was calculated from O 2 consumption (17). Table 1 summarizes these values for the two different conditions. Table 1 also reports that anaplerotic flux (relative to TCA cycle flux) was significantly elevated in the presence of propionate as expected. There was no significant change in phosphorylation at serine 293 of PDH as measured in Western blots in hearts supplied with propionate (data not shown).
The effects of unlabeled propionate on conventional 13 C NMR spectra from extracts of hearts supplied with [1,2-13 C 2 ]acetate plus unlabeled glucose are illustrated in Fig. 1 . In addition to the dominant glutamate resonances, the spectra also show resonances of malate, citrate, and aspartate, with malate and citrate being higher when propionate is supplied (Fig. 1B) . The insets in Fig. 1 show the glutamate C2, C3, and C4 resonances. Isotopomers of glutamate that have three or more carbons labeled consecutively produce doublets of doublets, marked Q for quartet when the J-couplings are resolved, or T for triplet when they are degenerate as occurs in carbon 3 of glutamate. Glutamate labeled in positions 3, 4, and 5 is derived from the condensation of [U- 13 C]acetyl-CoA with [2-13 C]oxaloacetate and its subsequent forward flux to ␣-ketoglutarate and exchange into the glutamate pool.
The relative areas of the multiplets in each glutamate resonance provide a direct read-out of substrate preferences and anaplerosis under steady-state isotopic conditions (17, 19 -21 Anaplerosis (Ys) is expressed as a fraction of citrate synthase flux (TCA cycle turnover). Anaplerosis, y, is significantly different (P Ͻ 0.001).
The dominant signal from [3,4,5-13 C 3 ]glutamate C4 (the doublet of doublet, or quartet) indicates qualitatively that a high fraction of acetyl-CoA was derived from exogenous [1,2-13 C 2 ]acetate (Fig. 1A) . The [3,4,5- 13 C]glutamate isotopomer is decreased in the presence of propionate as evidenced by the increase in the relative fraction of the D45 doublet versus the C4Q fraction (Fig. 1B) . This isotopomer is produced by the condensation of [U- 13 C]acetyl-CoA with oxaloacetate that is not labeled in the C2 position. Under these conditions, unenriched propionate increases the fraction of OAA that is not labeled. The relevant pathways are summarized in Fig. 2 (Fig. 1B) .
Because the heart was clamped less than 3.5 min after addition of [1- 13 C]pyruvate, the 13 C NMR spectrum is dominated by isotopomers generated before addition of pyruvate. Conventional isotopomer analysis was used to measure anaplerosis and the fraction of acetyl-CoA derived from [1,2-13 C 2 ]acetate (20) . After the introduction of [1- 13 C]pyruvate, metabolism through PDH could briefly provide a new source of unenriched acetyl-CoA. In hearts supplied with acetate and glucose, 98% of acetyl-CoA was derived from [1,2-13 C 2 ]acetate. Among the hearts supplied with acetate, glucose, and propionate, the same amount of acetyl-CoA was derived from [1,2-13 C 2 ]acetate, as measured by the fraction of C5D/ C5S. The singlet was assumed to be derived from natural 1 H-Decoupled 13 C NMR spectra of tissue extracts. Thermally polarized 13 C NMR spectra of tissue extracts of hearts perfused to steady state with unlabeled glucose and [U- 13 C]acetate and exposed briefly to hyperpolarized (HP)-[1-13 C]pyruvate are illustrated over the chemical shift range of ϳ25 to 57 ppm. In the absence of propionate (A), both acetyl-CoA and oxaloacetate must be highly enriched as measured by the high fractional contribution of the quartets (in C2 and C4) or triplets (in C3) of glutamate. Hearts supplied with propionate (B) showed an increase in the doublet, D45, relative to the quartet, indicating lower 13 C enrichment in oxaloacetate. Propionate also induced an increase in citrate and malate abundance. C: concentrations (conc.) of lactate and alanine as measured by quantitative 1 H NMR of the heart extracts. Addition of propionate to the perfusion medium resulted in a decrease in the alanine concentration in the heart. D: fractional enrichments of the C1 position of lactate and alanine as measured by proton NMR of the methyl protons and 3 bond j-couplings to the C1 position. Alanine is more enriched than lactate in both perfusions conditions, although the difference is accentuated in the presence of propionate. abundance 13 C. Separate bench experiments using [U- 13 C]glucose and [2- 13 C]acetate confirmed that acetate was the overwhelming source of acetyl-CoA; less than 3% of acetyl-CoA was derived from glucose either in the presence or absence of propionate. These experiments confirmed that exogenous glucose was not metabolized in the TCA cycle via either PDH or pyruvate carboxylase, consistent with earlier studies of isolated rat hearts (20) .
1 H NMR spectra of these same samples indicated that propionate resulted in a significant decrease in total tissue alanine and a trend toward lower lactate (Fig. 1, C and D) . The lactate-to-alanine ratio was not significantly different. Similarly, the fractional 13 3 J CH values to the methyl protons, but inspection of the 13 C spectra allow the couplings to be assigned exclusively to labeling at the C1 position. This provides direct evidence showing that exogenous [1- 13 C]pyruvate exchanges more fully with tissue pools of alanine than it does with tissue lactate, as reported previously (31) .
Effect of propionate on metabolism of hyperpolarized [1- 13 C]pyruvate. Mouse hearts were studied in the 10 mm 13 C optimized cryoprobe. All four possible biochemical fates of [1- 13 C]pyruvate, illustrated in Fig. 3 , could be directly detected in the functioning mouse heart. Metabolism of pyruvate to lactate, alanine, or bicarbonate could be monitored in real time, and the fourth possibility -carboxylation via pyruvate carboxylase -could be detected in summed spectra. Spectra obtained by summing the 25 individual spectra with the highest signal following injection with hyperpolarized [1-13 C]pyruvate are shown in Fig. 4 13 C is indicated by filled circles, and each carbon position is numbered from left to right. The isotopomers presented assume 1 turn of the TCA cycle has been completed with labeled acetate present, hence the symmetric enrichment of the OAA pool. Under these conditions, neglecting natural abundance 13 C, the acetyl-CoA pool is either [1,2- 13 C2]acetyl-CoA or unlabeled. Consequently, the C4 signal of glutamate is either a doublet due to labeling in carbons 4 and 5, or a doublet of doublets due to labeling in positions 3 and 4 and 5. In the presence of propionate, the fraction of unenriched OAA is increased and, consequently, the fraction of ␣-ketoglutarate labeled simultaneously in carbons 3 and 4 and 5 decreases. The dashed rectangle indicates ␣-ketoglutarate derived from 13 C-labeled OAA. PDH, pyruvate dehydrogenase. Fig. 3 . Metabolism of [1-13 C]pyruvate. Flux through PDH leads to production of 13 CO2, but there are 3 other possible sources in a single turn of the TCA cycle. After carboxylation by PC, the 13 C label can become symmetrized by exchange between malate and fumarate (faded circle). Subsequent flux through the malic enzyme produces 13 CO2 but the fractional enrichment has a maximal value of 50%. Alternatively, after carboxylation, a forward turn of the TCA cycle could eliminate a 13 CO2 at the step of isocitrate dehydrogenase (shaded circle). This pathway could have a maximal enrichment equal to the exogenous pyruvate. Finally, after symmetrization at fumarate, a forward turn of the TCA cycle could produce a 13 CO2 at ␣-ketoglutarate dehydrogenase.
13 C]alanine, and H 13 CO 3 Ϫ were observed. In hearts supplied with propionate in the perfusion media, there was a marked increase in the signal intensity of HP [
13 C]bicarbonate and a small decrease in signal intensities of aspartate and malate. The increase in the malate signal in conventional 13 C NMR spectra shows that the pool size of malate is increased by propionate (Fig. 1) , a well-known effect (40) , yet the HP malate signal was reduced.
Representative time-intensity curves for [1-13 C]lactate, [1-13 C]alanine, H 13 CO 3 Ϫ , and 13 CO 2 are shown in Fig. 5 . The most striking differences were in the magnitude of the [ 13 C]bicarbonate and 13 CO 2 signals in the presence of propionate. An alternative approach to display data such as this is to normalize the total signal intensity derived from pyruvate and its metabolites and graph the hyperpolarized "activities" of each, i.e., taking the area under the curve for the time evolution of each metabolite (Fig. 6) (11) . The integrated [
13 C]bicarbonate intensity was ϳ37 times higher in the presence of propionate (P Ͻ 0.01). Other significant differences were found for alanine (P Ͻ 0.01), aspartate-C1 (P Ͻ 0.01), aspartate-C4 (P Ͻ 0.01), and for 13 CO 2 (P Ͻ 0.01), which is in fast equilibrium with bicarbonate. No significant differences were observed for signals associated with lactate or either C1-or C4-labeled malate.
DISCUSSION
This experiment was designed to assess the effects of propionate on pyruvate metabolism in the presence of a high concentration of a fatty acid. Acetate was chosen because there is no question that it is the preferred substrate for oxidation by heart tissue when present in millimolar concentrations, and it therefore serves as a model for maximal substrate-induced suppression of PDH flux. These studies confirm that in the presence of high concentrations of acetate and glucose, the overwhelming majority of acetyl-CoA production in hearts was derived from acetate (20) . The current results further demonstrate that oxidation of HP [1- 13 C]pyruvate, even in a high concentration administered as a bolus, is nearly eliminated in the presence of acetate (27) . Oxygen consumption was not changed by propionate (Table 1 ), yet HP [
13 C]bicarbonate increased Ͼ30-fold (Fig. 5) . A much smaller increase in HP [ 13 C]bicarbonate was noted under conditions where malate was co-administered in vivo (34) . Administration of dichloroacetate also activates PDH flux, but side effects of the drug prevent its long-term usage medically (2, 12, 23) . This model is another condition where bicarbonate production from HP [1- 13 C]pyruvate is completely dissociated from myocardial oxygen consumption (25) . Earlier studies examined the effects of acetate or propionate, studied independently, on [1- 14 C]pyruvate metabolism and the rate of appearance of 14 CO 2 compared with the absence of either fatty acid. These studies suggest approximately threefold increase in 13 CO 2 could be expected in the presence of propionate. The current observation of Ͼ30-fold increase likely occurred for two reasons. First, more physiological concentration of pyruvate, ϳ0.1 mM, was used previously (14) . The current design delivered a much higher concentration of pyruvate, 2 mM. Although this is higher than the physiological concentration of pyruvate in normal plasma, millimolar concentrations of pyruvate are common and probably necessary for in vivo HP experiments (33) . A second factor in the large effect of propionate on [ 13 C]bicarbonate production is the control condition. In the study design, advantage was taken of the known effects of acetate on pyruvate oxidation and the anticipated marked suppression on the appearance of HP [
13 C]bicarbonate and 13 CO 2 in control hearts. The present results demonstrate that the stimulatory effects of propionate on PDH flux override the inhibitory effects of acetate on appearance of HP [
13 C]bicarbonate from HP [1-
13 C]pyruvate. Acetate is not subject to transport by carnitine palmitoyl transferase-I, nor is it ␤-oxidized. As such, it is the most avidly metabolized substrate available to the heart. The overwhelming preference of the heart for acetate underscores just how powerful the effects of propionate are on substrate selection. The activity of the PDH is regulated by reversible phosphorylations of multiple subunits and by inhibition by its end products, acetyl CoA and NADH. The phosphorylation state of PDH, in turn, is controlled by competing activity of pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase. In the absence of acetate, propionate caused almost complete dephosphorylation of PDH in rat hearts (14) . Under the current experimental conditions, with a high concentration of both acetate and propionate in group 2, the Western blot analysis did not demonstrate a measurable change in the phosphorylation state at serine 293 (data not shown). The effect of propionate on PDH flux could be due to trapping of CoA as propionyl-CoA rather than acetyl-CoA, with a consequent loss of end-product inhibition at PDH (41) . Alternatively, propionate could exert control through secondary phosphorylation sites on PDH (10) . Exact determination of the mechanism of PDH activation in this condition is the subject of ongoing research.
Pyruvate may also undergo carboxylation in the heart (20) as illustrated in Fig. 3 , which allows additional decarboxylation reactions that could serve as sources of HP [
13 C]bicarbonate (30, 38) . As illustrated in Fig. 4 13 C labeling observed in citrate and glutamate could only arise from decarboxylation of HP [2- 13 C]pyruvate by the PDH (data not shown). Together, these spectra indicate that the only significant source of [
13 C]bicarbonate is the product of pyruvate decarboxylation in PDH. These observations are consistent with previous findings in the rat heart (14, 20, 38) and further demonstrate the stimulatory effects of propionate on flux of exogenous pyruvate through PDH even in the presence of inhibition by short chain fatty acid metabolism.
In addition to its effects on pyruvate oxidation, exposure to propionate also stimulates anaplerosis in the heart (5, 14) . In this case, propionate itself is the anaplerotic substrate. After activation to propionyl-CoA and carboxylation to form methylmalonyl-CoA, it undergoes rearrangement to an intermediate of the citric acid cycle, succinyl-CoA (20, 22, 29, 38 ). In the current study, anaplerosis was stimulated by propionate, as reported previously (Table 1 ). The role of cardiac anaplerosis in health and disease is only partially understood, but it remains a potential target for therapy. Propionate itself has been suggested as a compound useful for replenishing depleted pools of TCA cycle intermediates (5), and propionyl-L-carnitine has beneficial effects in animal models and human subjects (6, 13) . There are currently no methods for detecting the effects of propionate on the human heart. Because multislice cardiac imaging of HP [
13 C]bicarbonate is feasible in the pig heart (15) and administration of HP [1- 13 C]pyruvate is safe in human patients (28) , extension of these results to human cardiac imaging is feasible.
The cytosol of the heart is considered by many as a homogeneous space where exogenous pyruvate presumably has free access to high-activity cytosolic enzymes such as lactate dehydrogenase and alanine aminotransferase. Nevertheless, earlier studies (7, 30, 31) found that 14 C labeling in alanine and lactate derived from exogenous [1- 14 C]pyruvate was not consistent with a single pool of pyruvate freely exchanging with alanine and lactate. The current results confirm earlier studies with 14 C that alanine enrichment is consistently significantly higher than lactate (Fig. 1D) , and this discrepancy is enhanced by propionate. Furthermore, as elucidated in the [U- 13 C]glucose experiment (data not shown), considerable lactate was produced in these hearts via glycolysis, yet little of that carbon source was oxidized in the TCA cycle (0 -3%). The appearance of [ 13 C]bicarbonate generated from [1-13 C]pyruvate is not proportional to glucose oxidation. Glucose and pyruvate, under certain conditions, can have very different metabolic fates in the myocardium. Future experiments that vary the perfusion conditions will test whether this conclusion can be further generalized in the perfused heart. In general, the HP 13 C signal from any metabolite is proportional to (fractional enrichment)·(polarization)·(concentration). Because we have shown here that exogenous [1- 13 C]pyruvate does not equilibrate with total lactate in heart tissue, the HP [1-
13 C]lactate signal must also underestimate total tissue lactate in these experiments. Meticulous optimization of pulse sequence design has allowed imaging of HP [
13 C]bicarbonate and [1-13 C]lactate, but results here suggest that lactate derived from exchange with exogenous HP pyruvate might underestimate the size of the lactate pool (36) . Furthermore, the high alanine enrichment does not parallel lactate enrichment. Oftentimes, the lactate-to-alanine ratio is taken as a surrogate marker of the redox state of the cytosol. In this perfusion condition at least, assessing the redox state by making a ratio of the lactate to alanine signal intensity would lead to fallacious results. This study stresses the importance of gaining a complete understanding of the effect of the multiple compartments available to the heart in vivo.
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